SET STERIL NEFROSCOPIE România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

set steril nefroscopie

sc coramed medizinische produkte srl -

SET HISTEROSCOPIE România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

set histeroscopie

sc coramed medizinische produkte srl -

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Adempas Uniunea Europeană - română - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - hipertensiune arterială, pulmonară - antihipertensive pentru hipertensiunea arterială pulmonară - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. eficacitatea a fost demonstrată într-un hap populației, inclusiv etiologii ale idiopatică sau ereditară pah sau htap asociată bolilor de țesut conjunctiv. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Mydoptic 25 mg/ml picături oftalmice, soluţie Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

mydoptic 25 mg/ml picături oftalmice, soluţie

liqvor saÎ - phenylephrinum - picături oftalmice, soluţie - 25 mg/ml

BENOXI 4 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

benoxi 4 mg/ml

unimed pharma spol. s.r.o. - republica slovaca - oxybuprocaini hydrochloridum - pic. oft., sol. - 4mg/ml - anestezice locale anestezice locale

OFTACAIN 4 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

oftacain 4 mg/ml

rompharm company s.r.l. - romania - oxybuprocaini hydrochloridum - pic. oft., sol. - 4mg/ml - anestezice locale anestezice locale

Vermicid 10 Republica Moldova - română - ANSA (Agenţia Naţională pentru Siguranţa Alimentelor)

vermicid 10

sc delos impex 96 srl,românia - albendazol - suspensie antiparazitară - бычий, овечий

Misofar 200 mcg comprimate vaginale Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

misofar 200 mcg comprimate vaginale

bial-portela & cª., s.a. - misoprostolum - comprimate vaginale - 200 mcg

Cyclodol comprimate 2 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cyclodol comprimate 2 mg

centrul stiintific de producere "uzina chimico-farmaceutica borsceagov" sai - trihexyphenidylum - comprimate - 2 mg